- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00713804
Impact of Genetic Counseling for Individuals With Mental Illness
Genetic Counseling for Individuals With Mental Illness: Impact on Knowledge, Risk Perception, Perceived Control and Internalized Stigma.
People who have experienced mental illnesses like schizophrenia, bipolar disorder or schizoaffective disorder often have a poor understanding of the causes of their illness, and that they are often very worried about how the illness affects their families. In particular, affected individuals worry that there is a high chance that any children that they have will become affected with the same illness. Often, because of this fear, affected individuals choose not to have children.
Genetic counseling is a process where information about the causes of illnesses, and about chances for family members of individuals with these illnesses to become similarly affected is provided in a supportive environment by a specially trained healthcare professional. This study will investigate whether genetic counseling can reduce perceptions of risk and stigma, and increase perceived control and knowledge about the causes of the illness, amongst individuals who have a major mental illness.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 4H4
- Centre for Complex Disorders, BC Mental Health and Addictions Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Fluent in English
- Have been diagnosed with schizophrenia, bipolar, or schizoaffective disorder
- Reside in BC, and be able to attend 3 study visits over 1.5 months
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GC
Genetic counseling (GC): One face-to-face genetic counseling session of 1-2hours duration, with a board certified or board eligible genetic counselor which will involve, documentation of a detailed family history, discussion of: the contributors to mental illness pathogenesis, illness risk reduction strategies, chances for family members to develop mental illness (if required), supportive counseling around living with illness/risk of illness/managing illness vulnerability, and referral to support organizations as required.
|
One face-to-face genetic counseling session of 1-2hours duration, with a board certified or board eligible genetic counselor which will involve, documentation of a detailed family history, discussion of: the contributors to mental illness pathogenesis, illness risk reduction strategies, chances for family members to develop mental illness (if required), supportive counseling around living with illness/risk of illness/managing illness vulnerability, and referral to support organizations as required.
|
|
Active Comparator: EB
Educational Booklet (EB): One educational booklet that provides information about the causes of mental illnesses, and the chances for relatives of affected individuals to develop mental illness will be provided to participants.
|
One educational booklet that provides information about the causes of mental illnesses, and the chances for relatives of affected individuals to develop mental illness will be provided to participants.
|
|
No Intervention: WT
Waitlist (WT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Knowledge, risk perception, stigma, perceived control
Time Frame: immediately post intervention and 1 month post intervention
|
immediately post intervention and 1 month post intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: William Honer, MD, University of British Columbia
- Principal Investigator: Jehannine Austin, PhD, CCGC, CGC, University of British Columbia
- Study Director: Erin Michalak, University of British Columbia
- Study Director: Catriona Hippman, MSc, University of British Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H07-02427
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Genetic Counseling
-
Brigham and Women's HospitalMyriad Genetics, Inc.CompletedBreast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast CancerUnited States
-
Kaiser PermanenteDana-Farber Cancer Institute; Columbia University; Emory University; University... and other collaboratorsCompleted
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)UnknownOverweight | Metabolic Syndrome | Pre-diabetesUnited States
-
University of UtahNational Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Genetic PredispositionUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
University of MinnesotaUniversity of South FloridaCompletedCardiovascular Diseases | Cancer | Genetic Condition | Prenatal Condition | Reproductive ConditionUnited States
-
University of PennsylvaniaCompletedParkinson DiseaseUnited States
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedAnxiety | Knowledge, Attitudes, Practice | Decision Making | Chromosome AbnormalityTurkey
-
University of PennsylvaniaCompletedAlzheimer Disease | Genetic Predisposition to Disease
-
M.D. Anderson Cancer CenterCompleted